What caused margin spike beyond 21% despite lower exports QoQ?

No inventory gains; driven by efficiency and higher utilization. When sales increase, expenses automatically reduce. Margins will remain similar (19-20%+) even after new capex starts.

How will the ramp-up of the new plant look like, and are there advance POs?

Ramp-up will be month-on-month; no annual POs in this industry. Expect 20-30%+ capacity utilization in the first year, conservatively around 30% by FY27-end, generating ₹250-300 Cr.

Update on the previously indicated major capex announcement after Aica's stake control?

Evaluating options but delaying announcement until next quarter; priority is to start the current new plant first. New capex will be in a product along laminates, not pure laminates, to strengthen domestic market.

Specific reasons for repeated delays in plant commissioning and risk of further delay?

Multiple reasons including family problem that slowed the project; now resolved. Trial runs ongoing; maximum by 1st September for commercial production, hopefully earlier (15th-20th August). No further risk seen.

What specific steps are being taken for domestic business turnaround and when will results show?

Restructuring team, getting new partners, opening warehouses, rebuilding trust with distributors. Results will be visible from Q3FY27 onwards, ramping up slowly.

How will domestic revenue share and EBITDA margins evolve as exports contract?

No contraction in exports; domestic revenue share (currently ~25%) may increase slowly. Margins expected to be similar as domestic operations are being structured efficiently.

What is the current tariff on US exports and is it impacting orders?

Duty remains at 10%; orders were being processed earlier and continue. Today's morning news indicated 10% continues.

Reason for 10% QoQ decline in employee cost and sharp variation in depreciation; what will be run-rate post new plant?

Last quarter included actuarial valuation for full year; Q1 doesn't. Employee cost will remain same as major hiring already done. Depreciation will kick in from next month onwards for new plant.

Stylam Industrie Q1 FY27 Earnings Call — Analysis (NSE: STYLAMIND)

Stylam surpasses 21% EBITDA margin in Q1FY27; new laminate plant to commence commercial production in September 2026 and contribute ₹250-300 Cr in FY27.

27 Jul 2026 · Analysis by Alpha Inflection

The take

Q1FY27 EBITDA Margin >21% . New guidance — FY27 revenue contribution from new l… ₹250 Cr to ₹300 Cr . New story: Domestic distribution revamp .

Results

Q1FY27 EBITDA margin exceeded 21%, driven by operating efficiencies and higher utilization; revenue growth led by exports, while domestic losses were reduced.

Financial highlights

Stylam Industrie Q1 FY27 reported figures
Metric	Value	Change	Basis
EBITDA Margin	>21%	+improved from ~20%	point_in_time · Q1FY27 · versus previous ceiling of ~20%

Guidance

New laminate plant to generate ₹250-300 Cr revenue in FY27 at 19-20%+ margins; domestic restructuring expected to show improvement from Q3FY27.

What management committed to

EBITDA margins will sustain at 19% to 20% plus even after the new capex starts at end of August. — 19%, 20% plus, FY27
[The new laminate plant] will achieve 30% plus capacity utilization in the first year (by end of FY27) on a conservative basis. — 30% plus, FY27
Revenue from [the new laminate plant] will be ₹250 Cr to ₹300 Cr in FY27. — ₹250 Cr to ₹300 Cr, FY27
Commercial production of [the new laminate plant] will start by 1st September 2026, with a possibility of 15th-20th August 2026. — 1st September 2026, Q2FY27
[Stylam's] domestic business restructuring will show results from Quarter 3 (Q3FY27) onwards, with a ramp-up in volume. — Q3FY27
[Stylam] will announce a new capex (not pure laminates, but a product along laminates) in the next quarter, after the current new plant is operational. — Q2FY27
Employee cost will remain at the same level as Q1FY27 going forward, as all major hiring for the new plant has already been done. — same as Q1FY27, FY27
There will be no contraction in the export market; the domestic revenue share (currently ~25%) may increase slowly but exports will not decline. — FY27
Losses in the domestic market have been reduced, and the domestic operations are now being run efficiently so that they do not hamper overall margins.

Key themes

Capacity ramp-up, domestic revamp, and export resilience

How the narrative shifted

Domestic distribution revamp: Management is rebuilding the domestic laminates channel with new team, distributors, and warehouses to revive the stagnant ~25% revenue share, targeting results from Q3FY27.
New plant commissioning & ramp: The delayed third laminate plant is now in trial runs and will commercially produce by September 2026, with conservative FY27 utilization of 30% and revenue of ₹250-300 Cr.
Export resilience & tariff uncertainty: Exports remain strong across Europe, APAC, Middle East; US duty stayed at 10% removing an overhang, but logistics challenges persist globally.
Raw material & pricing stability: Phenol and melamine prices are stable; no further domestic price hikes planned unless input costs spike. War-driven uncertainty remains the key variable.
Aica partnership as passive tech conduit: Aica Kogyo's 40% stake is purely strategic with no operational involvement; technology transfer may happen eventually but no roadmap exists yet.
Capital allocation discipline: Next capex will be in a product adjacent to laminates to avoid saturating the laminate market, with a focus on strengthening domestic presence; announcement deferred to Q2FY27.

Operational commentary

New laminate plant (third plant) trial runs underway; commercial production targeted by 1st September 2026, delayed from earlier timelines due to rain and family issues.
Domestic laminates business restructuring: new team, distributors, and warehouses being added; meaningful volume ramp-up expected from Q3FY27.
Exports remained strong; Europe, APAC, and Middle East performing well; US tariff at 10% continues with no immediate change.
Aica Kogyo (Japan) has officially joined as a 40% strategic shareholder; no operational involvement yet; technology transfer possibilities to be explored in future.
Acrylic solid surfaces plant currently underutilised; new domestic and export plans in progress.
Raw material prices (phenol ~USD1,400/ton, melamine ~USD1,000-1,100) stable; no further price hikes expected unless situation worsens.

Analyst Q&A

Q. What caused margin spike beyond 21% despite lower exports QoQ?
No inventory gains; driven by efficiency and higher utilization. When sales increase, expenses automatically reduce. Margins will remain similar (19-20%+) even after new capex starts.
Q. How will the ramp-up of the new plant look like, and are there advance POs?
Ramp-up will be month-on-month; no annual POs in this industry. Expect 20-30%+ capacity utilization in the first year, conservatively around 30% by FY27-end, generating ₹250-300 Cr.
Q. Update on the previously indicated major capex announcement after Aica's stake control?
Evaluating options but delaying announcement until next quarter; priority is to start the current new plant first. New capex will be in a product along laminates, not pure laminates, to strengthen domestic market.
Q. Specific reasons for repeated delays in plant commissioning and risk of further delay?
Multiple reasons including family problem that slowed the project; now resolved. Trial runs ongoing; maximum by 1st September for commercial production, hopefully earlier (15th-20th August). No further risk seen.
Q. What specific steps are being taken for domestic business turnaround and when will results show?
Restructuring team, getting new partners, opening warehouses, rebuilding trust with distributors. Results will be visible from Q3FY27 onwards, ramping up slowly.
Q. How will domestic revenue share and EBITDA margins evolve as exports contract?
No contraction in exports; domestic revenue share (currently ~25%) may increase slowly. Margins expected to be similar as domestic operations are being structured efficiently.
Q. What is the current tariff on US exports and is it impacting orders?
Duty remains at 10%; orders were being processed earlier and continue. Today's morning news indicated 10% continues.
Q. Reason for 10% QoQ decline in employee cost and sharp variation in depreciation; what will be run-rate post new plant?
Last quarter included actuarial valuation for full year; Q1 doesn't. Employee cost will remain same as major hiring already done. Depreciation will kick in from next month onwards for new plant.

View source

Research and educational content only. Not investment advice.